<?xml version="1.0" encoding="UTF-8"?>
<p>IL-17, which is produced during the adaptive and innate immune responses, functions as a pro-cytokine and plays a critical role during H5N1 IAV infection (
 <xref rid="B35" ref-type="bibr">Wang et al., 2011</xref>; 
 <xref rid="B10" ref-type="bibr">Cypowyj et al., 2012</xref>). A recent study also demonstrated a protective role of IL-17A by modulating early humoral immunity (
 <xref rid="B36" ref-type="bibr">Wang et al., 2016</xref>). However, previous studies of IL-17RA-deficient mice reported that IL-17 may act as a double-edged sword by contributing to pulmonary immunopathology in pandemic H1N1 virus infection (
 <xref rid="B25" ref-type="bibr">Li et al., 2012</xref>; 
 <xref rid="B42" ref-type="bibr">Xue et al., 2017</xref>). Indeed, the H5N1-infected IL-17-deficient subjects display increased weight loss and reduced survival rates (
 <xref rid="B35" ref-type="bibr">Wang et al., 2011</xref>). However, the functions of IL-17A during IAV infection still need to be elucidated 
 <italic>in vitro</italic> and 
 <italic>in vivo</italic>.
</p>
